Cargando…
Time course of 75%–100% efficacy response of adjunctive brivaracetam
BACKGROUND: Time to sustained seizure frequency reduction can provide clinically meaningful epilepsy outcomes. AIMS OF THE STUDY: To examine the time course of brivaracetam (BRV) efficacy in adults with focal seizures and focal to bilateral tonic‐clonic seizures (FBTCS). METHODS: Post hoc analysis o...
Autores principales: | Klein, Pavel, Laloyaux, Cédric, Elmoufti, Sami, Gasalla, Teresa, Martin, Melinda S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422720/ https://www.ncbi.nlm.nih.gov/pubmed/32432339 http://dx.doi.org/10.1111/ane.13287 |
Ejemplares similares
-
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials
por: Ryvlin, Philippe, et al.
Publicado: (2022) -
A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein, Pavel, et al.
Publicado: (2018) -
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021) -
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021) -
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)